{"id":"W2332844714","doi":"10.1097/md.0000000000000198","title":"Neoadjuvant FOLFIRINOX Application in Borderline Resectable Pancreatic Adenocarcinoma","year":2014,"lang":"en","type":"article","venue":"Medicine","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"FOLFIRINOX; Medicine; Irinotecan; Oxaliplatin; Neoadjuvant therapy; Surgery; Concomitant; Adenocarcinoma; Radiology; Internal medicine; Colorectal cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001341986,0.0001878372,0.0008511532,0.0003453039,0.00006941421,0.000004662867,0.0001578954,0.0001496514,0.0004773994],"category_scores_gemma":[0.001174771,0.0001369295,0.00004280499,0.0005729401,0.0002507408,0.00004878764,0.00005211792,0.0003867469,0.0001909968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001515946,"about_ca_system_score_gemma":0.0001406866,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001683758,"about_ca_topic_score_gemma":0.0003184742,"domain_scores_codex":[0.9979262,0.0001484491,0.0005247623,0.0004077266,0.00049057,0.000502293],"domain_scores_gemma":[0.9985526,0.0004357211,0.0000905774,0.0005157696,0.0001355645,0.0002697864],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000387483,0.0002037329,0.9691414,0.0001951045,0.0000407966,0.00006514505,0.0003928653,0.000003435605,0.005439781,0.001630873,0.004955432,0.01754392],"study_design_scores_gemma":[0.007333244,0.001852227,0.9408426,0.0004007122,0.0001882122,0.0001416332,0.0002373679,0.01859076,0.0002023935,0.001529759,0.02852994,0.0001511532],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9219624,0.00242111,0.007168622,0.01934434,0.00008330966,0.00101007,0.000001366012,0.00008869693,0.04792007],"genre_scores_gemma":[0.9926706,0.0002659507,0.001236673,0.001277016,0.0006025756,0.0001781217,0.0000553205,0.00002879866,0.003684924],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07070822,"threshold_uncertainty_score":0.5583825,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02479493500741469,"score_gpt":0.3370445509532141,"score_spread":0.3122496159457994,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}